AirDoctor Introduces New AirDoctor 1500 Mini Tower, Bringing Hospital-Grade Air Quality to Smaller Spaces
Sleek, Compact Design Brings Premium Air Filtration To Bedrooms, Nurseries, and Home OfficesLOS ANGELES, Sept. 17, 2026 /PRNewswire/ — Ideal…
Science & Climate
Armor Health Expands Structured Approach to Women’s Postpartum Mental Health in Correctional Settings
MIAMI, Sept. 16, 2026 /PRNewswire/ — Armor Health (ArmorHealthcare.com), a national provider of correctional healthcare, is expanding its distinct, structured…
Miller Children’s & Women’s Hospital Performs First Minima Stent Procedure for Infants with Congenital Heart Conditions
First FDA-approved stent designed specifically for the smallest patients with certain congenital heart and vascular conditions.LONG BEACH, Calif., Sept. 14,…
Meant Health Expands Telehealth Access to FDA-Approved GLP-1 Prescriptions, Including Ozempic®
MANASSAS, Va., Sept. 12, 2026 /PRNewswire/ — Meant Health, a digital health platform that connects patients with licensed clinicians for evaluation,…
Planet Classroom Network Welcomes Climate Scientist David W. DuBois
Extreme Heat. Drought. Water Scarcity. New Net Zero Speaks Episode Explores Why Climate Change Is Becoming Increasingly LocalNew Mexico State…
Global Flavors Unite in Guangzhou: SIAL West Asia Exhibition Opens, Connecting the World’s F&B Pulse
GUANGZHOU, China, Sept. 5, 2026 /PRNewswire/ — A report from Iqingdao.On September 3, the 2026 SIAL West Asia International Food…
Astellas Doses First Patient in Phase 3 Study of ASP2138 in CLDN18.2-postive and HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
– ASP2138’s advancement into Phase 3 marks an important milestone in Astellas’ commitment to advancing research in CLDN18.2 with its…
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
SEONGNAM, South Korea, Aug. 23, 2026 /PRNewswire/ — Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene…
Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
TAIPEI, Aug. 23, 2026 /PRNewswire/ — Anbogen Therapeutics Inc. (TPEx: 7784) (“Anbogen” or the “Company”), a clinical-stage precision oncology company, today…
Zum Appoints Matthew Klein as VP of Software Sales
Klein will lead Zum’s software-only business as the company’s unified, AI-powered Zum CMX solution expands nationwide, reimagining student mobility for…
Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026Emerging Discovery Programs Build…
New Smart Cities Technologies Improve Public Services Enhance Efficiency
New Smart Cities Technologies Improve Public Services Enhance Efficiency Cities around the world are rapidly adopting smart technologies to improve…